Format

Send to

Choose Destination
Eur J Clin Microbiol Infect Dis. 2007 Jul;26(7):501-4.

Flucloxacillin treatment of Staphylococcus aureus meningitis.

Author information

1
Department of Infectious Disease, Level 6 Support Building, Auckland City Hospital, Park Road, Grafton, Auckland, 1023, New Zealand. sritchie@adhb.govt.nz

Abstract

In this paper, we aimed to evaluate the efficacy of flucloxacillin treatment of meningitis caused by methicillin-sensitive Staphylococcus aureus. We identified 33 patients with meningitis due to S. aureus; eight had community-acquired meningitis and 25 had neurosurgical meningitis. Six of the eight patients with community-acquired meningitis were cured. Eighteen of the 22 patients treated with flucloxacillin were cured without relapse (86%, 95%CI 65-97%) and their cerebrospinal fluid (CSF) cultures were sterile after a median of 3 days of treatment. The cure rate for 12 patients who also received an additional antibiotic at the outset of treatment was 75% (95%CI 43-95%). This was not different to the cure rate for the ten patients who received flucloxacillin alone 90% (95%CI 56-100%). We conclude that flucloxacillin is an effective treatment for meningitis caused by S. aureus.

PMID:
17554568
DOI:
10.1007/s10096-007-0324-2
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center